Pedram Argani Selected Research

Wilms Tumor (Wilm's Tumor)

1/2020	BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition.
11/2008	Synchronous bilateral Wilm's tumor with complete radiographic response managed without surgical resection: a report from the National Wilm's Tumor Study 4.
12/2007	Wnt signaling pathway analysis in renal cell carcinoma in young patients.
10/2006	Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
4/2006	Translocation carcinomas of the kidney after chemotherapy in childhood.
10/2005	Fate of bilateral renal lesions missed on preoperative imaging: a report from the National Wilms Tumor Study Group.
9/2003	Recent advances in pediatric renal neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedram Argani Research Topics

Disease

142	Neoplasms (Cancer) 04/2024 - 01/2002
54	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2003
48	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 06/2003
41	Carcinoma (Carcinomatosis) 11/2022 - 09/2002
27	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2002
12	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 04/2003
10	Kidney Neoplasms (Kidney Cancer) 12/2023 - 02/2005
9	Perivascular Epithelioid Cell Neoplasms 04/2024 - 04/2009
9	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 05/2004
9	Ductal Carcinoma 01/2022 - 04/2003
8	Adenocarcinoma 01/2021 - 01/2002
8	Cholangiocarcinoma 09/2017 - 12/2002
7	Carcinogenesis 11/2022 - 01/2003
7	Wilms Tumor (Wilm's Tumor) 01/2020 - 09/2003
7	Alveolar Soft Part Sarcoma 01/2016 - 06/2003
6	Angiomyolipoma 01/2023 - 01/2008
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2006 - 01/2002
5	Cysts 12/2023 - 05/2006
5	Genetic Translocation (Chromosomal Translocation) 11/2020 - 02/2007
4	Melanoma (Melanoma, Malignant) 11/2022 - 02/2013
3	Neuroblastoma 12/2023 - 12/2007
3	Tuberous Sclerosis (Bourneville's Disease) 11/2022 - 01/2012
3	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 11/2022 - 05/2004
3	Leiomyomatosis 01/2021 - 11/2014
3	Synovial Sarcoma (Synovioma) 01/2020 - 01/2003
3	Oxyphilic Adenoma (Oncocytoma) 12/2018 - 08/2013
3	Lobular Carcinoma 11/2017 - 12/2003
3	Papillary Carcinoma 11/2014 - 06/2006
3	Disease Progression 07/2012 - 03/2006
3	Breast Diseases (Breast Disease) 09/2006 - 12/2004
2	Desmoplastic Small Round Cell Tumor 12/2023 - 01/2003
2	Microphthalmos 01/2022 - 02/2020
2	Mesothelioma 01/2021 - 11/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2018 - 05/2011
2	Necrosis 01/2018 - 12/2006
2	Pathologic Complete Response 03/2016 - 12/2010

Drug/Important Bio-Agent (IBA)

41	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2002
23	Estrogen ReceptorsIBA 01/2022 - 03/2004
20	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2003
19	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2003
17	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2002
17	Cathepsin KIBA 12/2023 - 09/2008
14	Progesterone Receptors (Progesterone Receptor)IBA 03/2016 - 03/2004
13	RNA (Ribonucleic Acid)IBA 01/2024 - 05/2002
10	Messenger RNA (mRNA)IBA 01/2021 - 03/2003
10	Phenobarbital (Luminal)FDA Link 08/2015 - 02/2009
9	ParaffinIBA 12/2023 - 11/2002
8	Keratins (Keratin)IBA 12/2023 - 12/2002
8	EnzymesIBA 12/2021 - 01/2003
7	trans-sodium crocetinate (crocetin)IBA 04/2024 - 01/2018
7	Hormones (Hormone)IBA 01/2020 - 05/2006
6	MART-1 AntigenIBA 06/2023 - 01/2008
6	AntigensIBA 01/2023 - 12/2002
5	Formaldehyde (Formol)FDA Link 12/2023 - 01/2003
5	Glycoproteins (Glycoprotein)IBA 12/2023 - 12/2021
5	Fumarate Hydratase (Fumarase)IBA 01/2023 - 01/2018
5	TOR Serine-Threonine KinasesIBA 11/2022 - 09/2012
5	Anaplastic Lymphoma KinaseIBA 01/2022 - 06/2014
5	Estrogens (Estrogen)FDA Link 12/2015 - 06/2006
5	retinoic acid receptor betaIBA 09/2008 - 10/2003
5	Cyclin D2IBA 09/2008 - 12/2003
4	DesminIBA 12/2023 - 08/2013
4	ChromatinIBA 01/2021 - 04/2010
4	Phosphotransferases (Kinase)IBA 10/2020 - 08/2004
4	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2011 - 05/2004
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2010 - 01/2002
3	Keratin-7 (Cytokeratin 7)IBA 11/2023 - 11/2014
3	Cyclin D1IBA 01/2022 - 09/2003
3	S100 Proteins (S 100 Protein)IBA 01/2022 - 06/2006
3	Microphthalmia-Associated Transcription FactorIBA 01/2021 - 12/2007
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 10/2013
3	Estrogen Receptor alphaIBA 07/2018 - 09/2008
3	Epidermal Growth Factor (EGF)IBA 11/2017 - 03/2016
3	Carrier Proteins (Binding Protein)IBA 01/2015 - 12/2013
3	Androgen Receptors (Androgen Receptor)IBA 09/2014 - 02/2012
3	MucinsIBA 11/2013 - 12/2006
3	hydrogen sulfite (bisulfite)IBA 02/2009 - 01/2002
3	beta CateninIBA 12/2007 - 09/2003
3	MethyltransferasesIBA 05/2007 - 10/2003
3	MesothelinIBA 03/2004 - 09/2003
2	MTOR InhibitorsIBA 04/2024 - 05/2021
2	Keratin-20 (Cytokeratin 20)IBA 12/2023 - 11/2022
2	Carbonic Anhydrase IXIBA 11/2023 - 12/2010
2	Polytetrafluoroethylene (Teflon)FDA Link 11/2022 - 02/2005
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2022 - 01/2022
2	Neurofibromin 2 (Merlin)IBA 11/2022 - 01/2020
2	VinculinIBA 01/2022 - 06/2014
2	Epithelial Cell Adhesion MoleculeIBA 12/2021 - 10/2010
2	ChromograninsIBA 11/2021 - 12/2018
2	SynaptophysinIBA 11/2021 - 12/2018
2	InterferonsIBA 08/2021 - 08/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 01/2019
2	Coloring Agents (Dyes)IBA 10/2018 - 12/2016
2	MicroRNAs (MicroRNA)IBA 01/2017 - 06/2014
2	LigandsIBA 03/2016 - 10/2004

Therapy/Procedure

42	Therapeutics 12/2023 - 05/2004
15	Drug Therapy (Chemotherapy) 04/2024 - 09/2005
13	Nephrectomy 01/2022 - 10/2005
6	Mastectomy (Mammectomy) 01/2020 - 07/2006
2	Neoadjuvant Therapy 03/2016 - 07/2015